Entod Pharmaceuticals Enters In Medical & Cosmetic Skincare Market

July 19, 2022

“ENTOD Beauty London is a UK based skincare company internationally recognized as an expert in the commercialization of advanced and innovative research-based dermatological therapies”

Mumbai, July 19, 2022:

ENTOD Pharmaceuticals recently launched its dermatological venture in India in collaboration with its UK sister concern ENTOD Beauty London Ltd. In the UK & Europe, ENTOD Beauty London is a recognized player for over 25 years industry that specializes in advanced skin formulation research and development and commercialization of innovative dermatological therapies.

ENTOD Beauty London is known globally to use the latest technologies to design and develop innovative skincare and beauty solutions with the help of specialised skin and eye researchers in their state-of-the art GLP accredited research laboratories. It owns and successfully runs global specialty skincare brands such as Lashfactor, Vasuki, NuBase & Hairtop.

ENTOD Beauty London products will now be sold in India through Entod Pharmaceuticals nationwide sales field representative & distributor networks. The UK developed products will be manufactured in India under the Make in India Initiative and through a technology transfer arrangement between the two companies.

“Due to the massive success of our skincare products in the UK and across Europe, we are confident that the Indian initiative will also follow the same trajectory. The products intended for India have been specially designed for Indian skin types after detailed consultations with Indian dermatologists and skincare experts.

A successful Indian venture will also allow us to build a better global brand presence and keep innovating in the medical & cosmetic dermatology segments” said Dana Grossman, General Manager of ENTOD Beauty London Ltd.

Two of Entod Beauty London’s skincare products that have created a roar in global markets in recent times are Lashfactor and Vasuki. Lashfactor is the world’s first clinically tested nanotechnology-based eyelash and eyebrow prostaglandin growth serum that is developed to enhance & give more prominent eyelashes & eyebrows.

Vasuki on the other hand is a synthetic tripeptide snake venom serum complex that gently relaxes muscle contractions under the skin, and has shown in clinical studies to reduce both dynamic and static lines & wrinkles in early ageing skin.

“The launch of our Entod Beauty Londonderma division in India is an exciting time for the ENTOD International Group as it allows us to further cement our position in speciality healthcare in India and at the same time push these innovative skincare therapies to South-East Asia, Africa and other emerging markets.

The Government of India’s Make in India initiative has inspired us to bring some of the world’s best skincare treatments to India and give Indian patients more choices for their skincare. Entod Beauty London products will bridge the gaps in medical and cosmetic skin care in India, and also pave the way for more Indian skin-centred products. We are also excited to bring world-renowned skincare brands such as Lashfactor and Vasuki to our country and engage in further skincare research here through collaborations with Indian dermatologists” said Mr Nikkhil K Masurkar, Executive Director, ENTOD Pharmaceuticals.

healthysoch

Stay informed with the latest news from HealthySoch. Sign up today for exclusive insights and updates!

We promise we never spam!

Leave a Reply

Your email address will not be published.

Columnists

HealthySoch

Don't Miss

Sleeping Pill Use Linked to Later Increase in BP Meds

healthysoch New Delhi, April 16, 2019 : The use of
Sovereign Health Strikes Back at Law Enforcement Officials' "Raid"

Sovereign Health Strikes Back at Law Enforcement Officials’ “Raid”

CEO calls invasion “retaliation from a bunch of jack-booted thugs”